Early Registration Savings Deadline Expires In:
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!,
San Diego Convention Center, San Diego, California
Access ground breaking bioprocessing, manufacturing & supply chain strategies to revolutionize your cell, gene and CAR-T clinical and late stage programs.
Learn how industry leaders are driving the successful commercialization of these life changing products
Access Novel Science from the Brightest Minds in Cell & Gene Therapy Manufacturing
Access Key Industry Updates & Scientific Insights Across the Cell & Gene Therapy Spectrum
Monitoring Quality Across the Process - Process and Automated Analytics for Cell and Gene Therapies
- Developing potency strategies for gene therapy products
- Augmenting Automated Analytics for Cell & Gene Therapy Manufacture
- Analytical tools for a fast and robust commercial vector process
- Evolution in gene transfer technology and its potential role in saving money longer term
Technologies and Novel Platforms for Efficient Upstream and Downstream Processes
- Closed, automated and controlled upstream processing for iPSC-derived cell therapies
- Upstream Raw Material Variation Monitoring and Control Strategies
Strategies for Optimized Process Development
- Manufacturing Process & Product Development Efforts
- Process Validation and CPV for Cell and Gene Therapy
- Creation of Fit-for Purpose Devices and an All-in-One Automated Platform
Translation from Small to Commercial Scale Manufacturing
- Large scale gene modification
- Strategizing an economically viable manufacturing journey
- Instrumentation and mechanisms to drive efficient therapies
Critical Challenges in Effective Scalability
- Reinvention and Optimization of Vector Production
- New manufacturing models for autologous cell therapies
Manufacturing Feasibility: Ensuring a Financially Viable Strategy
- Gene therapy productivity: Viral vector supply and demand
- Feedback from the Industry Alliance Partnership (IAP) & CIRM Partnership and Commercialization Opportunities
- PANEL: CMO landscapes for new product initiatives: Novel outsourcing models
Single-Use Technologies for Cell and Gene Therapies
This 1-day hands-on course (held on August 10, 2020) provides an Introduction to Single-Use Technologies and the specific attributes and quality needs when implementing Single-Use Technologies in Cell and Gene Therapy Manufacturing. Course participants will experience the latest Single-Use products first hand during the lab portion of the course.
Course Instructor: James Dean Vogel, P.E., Founder of The BioProcess Institute
Connect with Global Scientists and Decision Makers Working Across Cell & Gene Therapy
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
(Companies A-L) Contact Jennifer Wickett: JWickett@knect365lifesciences.com | +1-857-504-6694
(Companies M-Z) Contact Blake Shuka: BShuka@knect365lifesciences.com | +1-857-504-6684